Achieve Life Sciences, Inc. Payments to Acquire Investments
Achieve Life Sciences, Inc. (ACHV) reported Payments to Acquire Investments of $24.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-03-24
- Achieve Life Sciences, Inc. payments to acquire investments for the quarter ending 2024-12-31 was $930.00K.
- Achieve Life Sciences, Inc. payments to acquire investments for the quarter ending 2024-09-30 was $389.00K.
- Achieve Life Sciences, Inc. payments to acquire investments for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Achieve Life Sciences, Inc. payments to acquire investments for the quarter ending 2019-09-30 was $0.00.
- Achieve Life Sciences, Inc. payments to acquire investments for fiscal 2025 was $24.75M, a 48.31% decline from fiscal 2024.
- Achieve Life Sciences, Inc. payments to acquire investments for fiscal 2024 was $47.89M.
- Achieve Life Sciences, Inc. payments to acquire investments for fiscal 2019 was $25.00K, a 99.55% decline from fiscal 2018.
- Achieve Life Sciences, Inc. payments to acquire investments for fiscal 2018 was $5.54M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.75M 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.32M derived: sum of 2 quarters · filed 2026-03-24 | $47.89M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $46.96M 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $46.57M 10-Q · filed 2024-08-13 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $5.00K derived: sum of 3 quarters · filed 2022-03-10 | $25.00K 10-K · filed 2022-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $5.00K derived: sum of 2 quarters · filed 2020-11-12 | $25.00K 10-Q · filed 2020-11-12 | $4.17M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $25.00K 10-Q · filed 2020-08-06 | $4.17M derived: sum of 3 quarters · filed 2021-03-11 | |
| 2019-03-31 | $20.00K 10-Q · filed 2020-05-14 | $4.17M derived: sum of 2 quarters · filed 2021-03-11 | ||
| 2018-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.54M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $1.39M 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |